✦ LIBER ✦

Gefitinib effective for patients with NSCLC and mutations in the EGFR gene

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EGFR/KRAS Mutations and Gefitinib Therap

✍ Wang, Zhen; Wu, Yi Long; Zhang, Guo Chun; Zhou, Qing; Xu, Chong Rui; Guo, Ai Lin 📂 Article 📅 2008 🏛 S. Karger AG 🌐 English ⚖ 108 KB

Comparison of gefitinib and erlotinib in

✍ Wu, Jenn-Yu; Wu, Shang-Gin; Yang, Chih-Hsin; Chang, Yih-Leong; Chang, Yeun-Chung 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 152 KB

E46. Clinical and biological implication

✍ Mitsudomi, Tetsuya 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 38 KB

35 The first 12 months of UK diagnostic

✍ Butler, R.; Clark, C.; Deans, Z.; Durkie, M.; Gonzalez, D.; Taniere, P.; Wallace 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Three Years of the Gefitinib UK Single P

✍ Vioix, H.; Franzen, S.; Selby, D.; Collomb, D.; Hauch, O.; Emmas, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

17 Use of Gefitinib (Iressa) in patients

✍ Plant, R.; Chetiyawardana, S.; Thompson, J.; Williams, S.; Ghafoor, Q. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 43 KB